Johnson & Johnson (JNJ) valuation, revenue & earnings

P/E and P/S history, revenue and growth, ROIC vs. cost of capital, segments, earnings and analyst forecasts

At a glance
Market capitalisation$652B
Moat ratingWide moat
ValuationExpensive
Revenue, and where it comes from$94.2bn in 2025: Innovative Medicine $60.4bn (64%), MedTech $33.8bn

Recent years are exact, taken from company filings; the earliest years are approximate. Forecast figures are Wall Street consensus, not company guidance. Read the full Johnson & Johnson moat analysis →